Status | Study |
RECRUITING |
Study Name: Reducing Risk for Infective Endocarditis Condition: Bacteremia Date: 2023-01-31 Interventions: Participants will be instructed on the Modified Bass technique for toothbrushing: brushing with a soft bristled toothbrush held at a 45 degree angle t |
Not yet recruiting |
Study Name: A New Model of Acute Febrile Disease Condition: Immobilization, Tonic Fasting Endotoxemia Date: 2017-05-16 Interventions: Other: LPS, 36 hour immobilization and fast LPS endotoxin is administered on study day 1 and immobilizat |
Recruiting |
Study Name: Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia Condition: Staphylococcus Aureus Bacteremia Right-Sided Staphylococcus Aur Date: 2017-05-15 Interventions: Biological: CF-301 CF-301, 0.2 |
Not yet recruiting |
Study Name: Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis Condition: Infective Endocarditis, Bacteremia Date: 2017-05-09 Interventions: Drug: Dalbavancin Dalbavancin |
Not yet recruiting |
Study Name: Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis Condition: Bacteremia Infective Endocarditis Date: 2017-05-05 Interventions: Procedure: Blood Culture For each patient, one single high volume blood culture (3 aerobic and 3 anaerob |
Not yet recruiting |
Study Name: Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia Condition: Staphylococcus Aureus Bacteremia Date: 2017-04-27 Interventions: Drug: Ceftobiprole medocaril C |
Completed |
Study Name: Candida Host Defense Response After Septic Shock in the Critically Ill Condition: Septic Shock Candidiasis Date: 2017-04-27 Interventions: Diagnostic Test: Candidiasis infection occurence Candidiasis infection occurence |
Recruiting |
Study Name: Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics Condition: Bacteremia Date: 2017-04-26 Interventions: Drug: DSTA4637S DSTA4637S will |
Recruiting |
Study Name: Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors Condition: Bacteremia Date: 2017-04-05 |
Not yet recruiting |
Study Name: Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia Condition: Bacteremia Date: 2017-03-30 Interventions: Drug: Continuous infusion of beta-lactam antibiotics . |